Eton Pharmaceuticals Inc.

13.29
0.53 (4.15%)
At close: Apr 02, 2025, 3:59 PM
13.00
-2.18%
After-hours: Apr 02, 2025, 04:39 PM EDT

Eton Pharmaceuticals Statistics

Share Statistics

Eton Pharmaceuticals has 26.82M shares outstanding. The number of shares has increased by 4.39% in one year.

Shares Outstanding 26.82M
Shares Change (YoY) 4.39%
Shares Change (QoQ) 0.69%
Owned by Institutions (%) 50.72%
Shares Floating 25.33M
Failed to Deliver (FTD) Shares 10
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 191.94K, so 0.72% of the outstanding shares have been sold short.

Short Interest 191.94K
Short % of Shares Out 0.72%
Short % of Float 0.76%
Short Ratio (days to cover) 0.93

Valuation Ratios

The PE ratio is -90.22 and the forward PE ratio is 33.08. Eton Pharmaceuticals's PEG ratio is -0.29.

PE Ratio -90.22
Forward PE 33.08
PS Ratio 8.84
Forward PS 1.5
PB Ratio 14.12
P/FCF Ratio 365.77
PEG Ratio -0.29
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Eton Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.

Current Ratio 2.06
Quick Ratio 1.29
Debt / Equity 0
Debt / EBITDA -0.04
Debt / FCF 0.11
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $1.26M
Profits Per Employee $-123.32K
Employee Count 31
Asset Turnover 0.51
Inventory Turnover 1.02

Taxes

Income Tax 15K
Effective Tax Rate -0.39%

Stock Price Statistics

The stock price has increased by 247.28% in the last 52 weeks. The beta is 1.37, so Eton Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.37
52-Week Price Change 247.28%
50-Day Moving Average 15.44
200-Day Moving Average 9.38
Relative Strength Index (RSI) 36.21
Average Volume (20 Days) 292.75K

Income Statement

In the last 12 months, Eton Pharmaceuticals had revenue of 39.01M and earned -3.82M in profits. Earnings per share was -0.15.

Revenue 39.01M
Gross Profit 23.41M
Operating Income -2.6M
Net Income -3.82M
EBITDA -2.6M
EBIT -2.6M
Earnings Per Share (EPS) -0.15
Full Income Statement

Balance Sheet

The company has 14.94M in cash and 107K in debt, giving a net cash position of 14.83M.

Cash & Cash Equivalents 14.94M
Total Debt 107K
Net Cash 14.83M
Retained Earnings -107.89M
Total Assets 76.12M
Working Capital 21.07M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 969K and capital expenditures -26K, giving a free cash flow of 943K.

Operating Cash Flow 969K
Capital Expenditures -26K
Free Cash Flow 943K
FCF Per Share 0.04
Full Cash Flow Statement

Margins

Gross margin is 60.01%, with operating and profit margins of -6.66% and -9.8%.

Gross Margin 60.01%
Operating Margin -6.66%
Pretax Margin -9.76%
Profit Margin -9.8%
EBITDA Margin -6.66%
EBIT Margin -6.66%
FCF Margin 2.42%

Dividends & Yields

ETON does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for ETON is $26, which is 103.4% higher than the current price. The consensus rating is "Strong Buy".

Price Target $26
Price Target Difference 103.4%
Analyst Consensus Strong Buy
Analyst Count 3
Stock Forecasts

Scores

Altman Z-Score 2.79
Piotroski F-Score 4